News 18 March, 2024Xinnate completes Phase 1a/b study with TCP-25 7 February, 2024Xinnate secures 100 million SEK in financing and applies for a patent for the treatment of Epidermolysis Bullosa 18 March, 2023Xinnate appoints Anna-Karin Lindqvist as new COO 19 October, 2022Approved clinical trial application for BioC gel on complex wounds 15 September, 2022Excellent results from phase I study shows that the BioC gel is safe and well tolerated. 15 July, 2022Funding secured for the next step of BioC clinical plan 1 July, 2022Xinnate is awarded a prestigious grant from the US Department of Defense 25 March, 2022Approved clinical trial application for First in Human study on BioC gel 20 August, 2021New publication: BioC-coated dressing shows promising effect on both infection and inflammation